Software as a Medical Device – also referred to as SaMD – is one of the fastest growing innovations in the medical device industry. As with any technology that experiences rapid adoption, challenges related to intellectual property protection often follow. In this series, we take a close look at IP considerations that SaMD developers should be aware of as they enter this market. In this podcast, Finnegan attorneys Susan Tull and Cory Bell explore challenges tech companies may face when developing SaMD.
Articles
California Brings First CCPA and Delete Act Enforcement Action Against Data Broker
September 4, 2026
European IP Blog
The Decision in G 1/25: A More Relaxed Approach to Description Amendments in Europe?
3 September 2026
Webinar
U.S. Discovery for Foreign Proceedings—28 USC § 1782 Requirements and Practice Tips
September 2, 2026
Webinar
Webinar
PTAB Developments and Their Impact on Parallel Litigation: Strategic Considerations
August 26, 2026
Webinar
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.